期刊文献+

新诊断2型糖尿病患者合并非酒精性脂肪肝临床分析 被引量:3

下载PDF
导出
摘要 目的探讨新诊断2型糖尿病(T2DM)患者发生非酒精性脂肪性肝病(NAFLD)的危险因素、临床特点。方法对山西医科大学第一附属医院139例新诊断T2DM的住院患者进行回顾性分析,其中合并NAFLD者65例,不合并NAFLD者74例。结果2型糖尿病合并脂肪肝组与无脂肪肝组比较,体重指数(BMI)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、空腹C肽(FCP)、餐后2hC肽(2hCP)、空腹胰岛素(FINS)、丙氨酸转氨酶(ALT)、胰岛素抵抗指数(HOMA-IR)以及24h尿白蛋白(24hUALB)有统计学意义(P<0.05或P<0.01);肥胖症、脂代谢紊乱、代谢综合征以及糖尿病肾病的发生率也明显增高(P<0.05或P<0.01);经Logistic回归分析,BMI、FCP和FINS是2型糖尿病并发脂肪肝的危险因素。结论肥胖、胰岛素抵抗及脂质代谢紊乱是2型糖尿病并发脂肪肝的主要危险因素。
作者 郭琳 杨静
出处 《中西医结合心脑血管病杂志》 2008年第8期976-978,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献9

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 2中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3053
  • 3范建高.代谢综合征与脂肪肝[J].国外医学(内分泌学分册),2002,22(5):273-275. 被引量:133
  • 4Cortez Pinto H, Chatham J, Chacko VP, et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: A pilot study [J]. JAMA, 1999, 282(17):1659-1664.
  • 5Kelley DE,McKolanis TM, Hegazi RA,et al. Fatty liver in type 2 diabetes mellitus: Relation to regional adiposity, fatty acids, and insulin resistance[J]. Am J Physiol Endocrinol Metab, 2003,285 (4) :E906 - E916.
  • 6魏双琴,韩树堂.非酒精性脂肪性肝病患者腰臀比测量的意义[J].医学研究生学报,2006,19(1):51-53. 被引量:20
  • 7Bugianesi E, Manzini P, D' Antico S, et a l. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver[J]. Hepatology, 2004,39(1):179- 187.
  • 8Marchesini G, Brizi M. Association of nonalcoholic fatty liver disease with insulin - resistance[J]. Am J Med, 1999,107(5) : 450 - 455.
  • 9Parvanova AI,Trevisan R,Iliev IP,et al. Insulin resistance and mi croalbuminuria; A crosssectional, casecontrol study 158 patients of with type2 diabetes and different degrees of urinary albumin excre tion[J]. Diabetes,2006,55(5):1456-1462.

二级参考文献28

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD single topic conference[J].Hepatology,2003,37 (5):1202-1209.
  • 3Thamer C,Machann J,Haap M,et al,Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects[J].Diabetes Care,2004,27(11):2726-2729.
  • 4Diehl AM,Li ZP,Lin HZ,et al.Cytokines and the pathogenesis of non-alcoholic steatohepatitis[J].Gut,2005,54 (2):303-306.
  • 5Kelley DE,McKolanis TM,Hegazi RA,et al.Fatty liver in type 2diabetes mellitus:relation to regional adiposity,fatty acids,and insulin resistance[J].Am J Physiol Endocrinol Metab,2003,285(4):906-916.
  • 6Berg AH,Scherer PE.Adipose tssue,inflammation,and cardiovascular disease[J].Circ Res,2005,96 (9):939 -949.
  • 7Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 8Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 9Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 10Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.

共引文献4653

同被引文献5

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部